Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Optimizing Endocrine Therapy for Metastatic Breast Cancer

Optimizing Endocrine Therapy for Metastatic Breast Cancer New therapies and advances in molecular biology provide opportunities for progress in the management of patients with advanced estrogen receptor-positive breast cancer. The near universal exposure of patients with early stage disease to endocrine therapy poses challenges of resistance when disease recurs. Analysis of tumor tissue at the time of recurrence, and after subsequent endocrine therapy where possible, is critical to understanding the most productive strategies for development and ultimately for individual patients. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Breast Cancer Reports Springer Journals

Optimizing Endocrine Therapy for Metastatic Breast Cancer

Loading next page...
 
/lp/springer-journals/optimizing-endocrine-therapy-for-metastatic-breast-cancer-q0zYdOr0OJ

References (63)

Publisher
Springer Journals
Copyright
Copyright © 2012 by Springer Science+Business Media, LLC
Subject
Medicine & Public Health; Surgical Oncology; Oncology; Internal Medicine
ISSN
1943-4588
eISSN
1943-4596
DOI
10.1007/s12609-011-0063-3
Publisher site
See Article on Publisher Site

Abstract

New therapies and advances in molecular biology provide opportunities for progress in the management of patients with advanced estrogen receptor-positive breast cancer. The near universal exposure of patients with early stage disease to endocrine therapy poses challenges of resistance when disease recurs. Analysis of tumor tissue at the time of recurrence, and after subsequent endocrine therapy where possible, is critical to understanding the most productive strategies for development and ultimately for individual patients.

Journal

Current Breast Cancer ReportsSpringer Journals

Published: Jan 7, 2012

There are no references for this article.